A groundbreaking international collaboration brought an innovative lung cancer immunotherapy from Cuba — CIMAvax-EGF — to Roswell Park Comprehensive Cancer Center. Now researchers at the Buffalo-based center are now examining whether this immunotherapy developed to treat lung cancer might prove to be an effective tool for preventing the often-deadly disease.

When cancer patients need a precise diagnosis or a second opinion, they rely on the expertise of Roswell Park Comprehensive Cancer Center’s Department of Pathology & Laboratory Medicine. Often called the “most important doctors you’ll never meet,” pathologists play a critical behind-the-scenes role to ensure proper staging and grading of disease, allowing care teams to develop personalized treatment plans. Acknowledging their dedication, Carl Morrison, MD, DVM, Chair of the Department, has recently announced several promotions within his team.